Free Trial

Adverum Biotechnologies (ADVM) Competitors

Adverum Biotechnologies logo
$2.38 +0.13 (+5.53%)
Closing price 07/3/2025 02:21 PM Eastern
Extended Trading
$2.33 -0.05 (-2.31%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADVM vs. CRGX, CYBN, EDIT, EPRX, ENGN, TLSA, CTMX, OGI, GNFT, and FDMT

Should you be buying Adverum Biotechnologies stock or one of its competitors? The main competitors of Adverum Biotechnologies include CARGO Therapeutics (CRGX), Cybin (CYBN), Editas Medicine (EDIT), Eupraxia Pharmaceuticals (EPRX), enGene (ENGN), Tiziana Life Sciences (TLSA), CytomX Therapeutics (CTMX), Organigram Global (OGI), GENFIT (GNFT), and 4D Molecular Therapeutics (FDMT). These companies are all part of the "pharmaceutical products" industry.

Adverum Biotechnologies vs. Its Competitors

CARGO Therapeutics (NASDAQ:CRGX) and Adverum Biotechnologies (NASDAQ:ADVM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

Adverum Biotechnologies has higher revenue and earnings than CARGO Therapeutics. CARGO Therapeutics is trading at a lower price-to-earnings ratio than Adverum Biotechnologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.97
Adverum Biotechnologies$1M49.82-$130.93M-$6.40-0.37

In the previous week, Adverum Biotechnologies had 2 more articles in the media than CARGO Therapeutics. MarketBeat recorded 2 mentions for Adverum Biotechnologies and 0 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 0.00 equaled Adverum Biotechnologies'average media sentiment score.

Company Overall Sentiment
CARGO Therapeutics Neutral
Adverum Biotechnologies Neutral

93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 48.2% of Adverum Biotechnologies shares are owned by institutional investors. 2.9% of CARGO Therapeutics shares are owned by insiders. Comparatively, 6.0% of Adverum Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

CARGO Therapeutics has a beta of 0.28, suggesting that its stock price is 72% less volatile than the S&P 500. Comparatively, Adverum Biotechnologies has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.

CARGO Therapeutics' return on equity of -45.93% beat Adverum Biotechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
CARGO TherapeuticsN/A -45.93% -39.58%
Adverum Biotechnologies N/A -130.53%-66.31%

CARGO Therapeutics currently has a consensus target price of $15.00, indicating a potential upside of 235.57%. Adverum Biotechnologies has a consensus target price of $23.80, indicating a potential upside of 897.90%. Given Adverum Biotechnologies' stronger consensus rating and higher possible upside, analysts clearly believe Adverum Biotechnologies is more favorable than CARGO Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CARGO Therapeutics
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86
Adverum Biotechnologies
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Summary

Adverum Biotechnologies beats CARGO Therapeutics on 9 of the 13 factors compared between the two stocks.

Get Adverum Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADVM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADVM vs. The Competition

MetricAdverum BiotechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$49.82M$2.89B$5.53B$9.02B
Dividend YieldN/A2.44%5.22%3.99%
P/E Ratio-0.3721.7127.7020.25
Price / Sales49.82283.26419.56119.26
Price / CashN/A41.7026.2128.59
Price / Book0.707.538.035.65
Net Income-$130.93M-$55.14M$3.18B$249.15M
7 Day Performance10.93%4.22%2.88%2.91%
1 Month Performance-15.72%0.91%1.67%4.11%
1 Year Performance-65.38%5.40%34.39%20.98%

Adverum Biotechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADVM
Adverum Biotechnologies
4.0838 of 5 stars
$2.39
+5.5%
$23.80
+897.9%
-65.4%$49.82M$1M-0.37190
CRGX
CARGO Therapeutics
1.4841 of 5 stars
$4.12
-1.7%
$15.00
+264.1%
-70.9%$193.20MN/A-0.89116Positive News
CYBN
Cybin
3.1208 of 5 stars
$8.39
+2.9%
$86.00
+925.0%
N/A$193.17MN/A-1.9250News Coverage
Analyst Revision
EDIT
Editas Medicine
4.1882 of 5 stars
$2.20
-3.5%
$4.70
+113.6%
-43.7%$190.87M$32.31M-0.72230
EPRX
Eupraxia Pharmaceuticals
2.4518 of 5 stars
$5.76
+8.7%
$11.00
+91.0%
+117.3%$190.57MN/A-7.5829Gap Up
High Trading Volume
ENGN
enGene
2.774 of 5 stars
$3.64
-0.5%
$23.29
+539.7%
-57.6%$187.04MN/A-2.2131
TLSA
Tiziana Life Sciences
0.6646 of 5 stars
$1.58
-1.3%
N/A+85.5%$186.96MN/A0.008Positive News
CTMX
CytomX Therapeutics
3.8297 of 5 stars
$2.27
+0.9%
$5.33
+134.9%
+93.0%$181.40M$138.10M4.73170
OGI
Organigram Global
0.5316 of 5 stars
$1.35
flat
N/A-10.4%$180.82M$117.47M13.50860News Coverage
GNFT
GENFIT
1.9744 of 5 stars
$3.73
+3.2%
$13.00
+249.0%
-8.2%$180.49M$67.00M0.00120Positive News
FDMT
4D Molecular Therapeutics
2.27 of 5 stars
$3.71
-3.4%
$29.56
+696.6%
-80.6%$177.89M$40K-1.17120

Related Companies and Tools


This page (NASDAQ:ADVM) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners